Active Clinical Research
Our center is actively recruiting patients for the following research protocols:
Lymphedema Early Detection
This protocol is open to patients at risk for lymphedema from prior lymph node removal and/or radiation therapy. Participation includes an on-site study visit every three months for a simple, painless, non-invasive measurement to detect excess fluid via bioimpedance spectroscopy. We will also be collecting a small blood sample.
Lymphedema Prevention
Based upon exciting preliminary animal studies, we believe that we have an effective and safe drug treatment strategy to prevent the appearance of lymphedema in patients at risk. This is a placebo controlled trial, in which active treatment occurs for one year following enrollment in the study. Periodic follow up visits following the first year of participation will be available at Stanford.
Lymphedema Drug Treatment
We have evidence from past animal studies that we have a safe drug treatment strategy to help restore lymphedema tissues toward normal. This is a double-blinded placebo controlled protocol, in which lymphedema patients are randomized to receive either the placebo or drug treatment. Patients receiving placebo will have the opportunity to receive a prescription for the active study medication at the end of the four month trial (as deemed appropriate by Dr. Rockson).
If you are interested in potentially participating in these studies, or have any research related questions, please call the clinical research coordinator at (650) 723-1396.
In order to see a list of Dr. Rockson’s scientific publications, please click here »